These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18564621)

  • 81. 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomized study.
    Bonneterre J; Hecquet B
    Eur J Cancer; 1994; 30A(7):1041-2. PubMed ID: 7946571
    [No Abstract]   [Full Text] [Related]  

  • 82. Assessing the comparative clinical value of tropisetron.
    Olver IN
    Aust N Z J Med; 1995 Oct; 25(5):523-7. PubMed ID: 8588777
    [No Abstract]   [Full Text] [Related]  

  • 83. Inhibition of apomorphine-induced vomiting by benzquinamide.
    Klein RL; Graves CL; Kim YI; Blatnick R
    Clin Pharmacol Ther; 1970; 11(4):530-7. PubMed ID: 4913868
    [No Abstract]   [Full Text] [Related]  

  • 84. 5-hydroxytryptamine-3 antagonists: a new class of potent antiemetics in cancer therapy.
    Soukop M
    Recent Results Cancer Res; 1991; 121():86-90. PubMed ID: 1650016
    [No Abstract]   [Full Text] [Related]  

  • 85. Support for ondansetron use.
    Nellgård P; Nellgård B
    J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):277-8. PubMed ID: 11312499
    [No Abstract]   [Full Text] [Related]  

  • 86. [New antiemetics: maropitant citrate].
    van Noort R
    Tijdschr Diergeneeskd; 2007 May; 132(10):411-2. PubMed ID: 17578239
    [No Abstract]   [Full Text] [Related]  

  • 87. Pharmacological prevention of postanesthetic shivering.
    Bilotta F; Rosa G
    Anesth Analg; 2002 Oct; 95(4):1125-6; author reply 1126. PubMed ID: 12351318
    [No Abstract]   [Full Text] [Related]  

  • 88. Idalopirdine: another disappointment for people with dementia.
    Le Couteur DG; Bateman B; Brayne C
    BMJ; 2018 Feb; 360():k753. PubMed ID: 29467153
    [No Abstract]   [Full Text] [Related]  

  • 89. Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis.
    Botrel TE; Clark OA; Clark L; Paladini L; Faleiros E; Pegoretti B
    Support Care Cancer; 2011 Jun; 19(6):823-32. PubMed ID: 20495832
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in Italy: pharmacologic, clinical and economic aspects].
    Pradelli L; Eandi M
    Tumori; 2008; 94(2):suppl 26-32. PubMed ID: 18564623
    [No Abstract]   [Full Text] [Related]  

  • 91. Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
    Hamadani M; Awab A; Chaudhary L; Tfayli A
    J Oncol Pharm Pract; 2006 Jun; 12(2):67-8. PubMed ID: 16984743
    [No Abstract]   [Full Text] [Related]  

  • 92. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
    Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T; Mitsuhashi S
    Lancet Oncol; 2009 Feb; 10(2):115-24. PubMed ID: 19135415
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Meta-analysis of phase III studies with palonosetron in the prevention of vomiting induced by moderately emetogenic chemotherapy].
    Di Maio M; Gallo C; Perrone F
    Tumori; 2008; 94(2):suppl 14-22. PubMed ID: 18564621
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.